You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR PSILOCYBIN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Psilocybin

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00302744 ↗	Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety	Completed	Heffter Research Institute	Phase 1	Psychiatric Research Study For Cancer Patients The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.
NCT00302744 ↗	Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety	Completed	Los Angeles Biomedical Research Institute	Phase 1	Psychiatric Research Study For Cancer Patients The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.
NCT00302744 ↗	Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety	Completed	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 1	Psychiatric Research Study For Cancer Patients The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Psilocybin

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Healthy	21
Major Depressive Disorder	15
Depression	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Depression	35
Depressive Disorder	33
Disease	21
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Psilocybin

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	93
Switzerland	13
Canada	12
United Kingdom	11
Denmark	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
Maryland	23
California	15
Connecticut	9
New York	8
Wisconsin	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Psilocybin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	2
Phase 2/Phase 3	1
Phase 2	65
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Not yet recruiting	64
Recruiting	49
Completed	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Psilocybin

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Johns Hopkins University	21
COMPASS Pathways	13
Heffter Research Institute	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Other	230
Industry	31
NIH	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.